Biologic therapies targeting type 2 inflammation in NSAID-exacerbated respiratory disease. [PDF]
Szatkowski P +3 more
europepmc +1 more source
The alarmin-ILC2 axis as a candidate mechanism for persistent olfactory dysfunction in allergic rhinitis. [PDF]
Zhu JX +6 more
europepmc +1 more source
Tezepelumab: redefining TSLP blockade in severe asthma through mechanistic precision and translational pharmacology. [PDF]
Mansour GK, Kumar S, Sukkarieh HH.
europepmc +1 more source
Improvement of Severe Volume Dependent Airway Closure With Tezepelumab: A Case Report. [PDF]
Suter P, Greig R, Chan R, Lipworth BJ.
europepmc +1 more source
First-in-human, phase 1 study of CM512, a TSLP/IL-13 bispecific antibody, in healthy volunteers: safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity. [PDF]
Cheng Y +12 more
europepmc +1 more source
Genetic associations of eosinophilic granulomatosis with polyangiitis in the Japanese population: exploring similarities and differences with European populations. [PDF]
Kawasaki A +28 more
europepmc +1 more source
openaire +2 more sources
Tezepelumab in severe asthma with pulmonary mucus plugs and eosinophilic chronic rhinosinusitis after dupilumab intolerance and suboptimal mepolizumab response: A case report. [PDF]
Senoo S +11 more
europepmc +1 more source
Alpha7 nicotinic acetylcholine receptor activation attenuates allergic airway inflammation and is associated with heme oxygenase-1 induction. [PDF]
Iriki J +13 more
europepmc +1 more source

